{"cik":2029039,"taxonomy":"us-gaap","tag":"CommonStockParOrStatedValuePerShare","label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","entityName":"NASUS PHARMA LTD.","units":{"ILS/shares":[{"end":"2024-12-31","val":0.01,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2024Q4I"}],"USD/shares":[{"end":"2024-12-31","val":0.01,"accn":"0001493152-25-029210","fy":2025,"fp":"Q2","form":"6-K","filed":"2025-12-29","frame":"CY2024Q4I"},{"end":"2025-06-30","val":0.01,"accn":"0001493152-25-029210","fy":2025,"fp":"Q2","form":"6-K","filed":"2025-12-29","frame":"CY2025Q2I"},{"end":"2025-12-31","val":0,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2025Q4I"}]}}